Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
When would you consider switching a patient with insulin-requiring Type 2 DM to an automated insulin delivery system?
Kudva, et al. PMID 40105270
Related Questions
Do you recommend the use of GLP1 R agonist therapy in patients with T1DM for weight loss?
After what time frame off GLP-1 RA therapy should you restart at the lowest starting dose?
Do you recommend neuromodulation treatments with an implantable device for patients with chronic painful diabetic neuropathy who have not responded to common oral therapies such as Gabapentin and Amitriptyline?
Is there a role for intermittent fasting as part of the management of a patient with long-standing type 2 diabetes and consistently poor glycemic control despite maximal therapy?
Do you recommend adding low-dose Aspirin for primary prevention in patients with Type 2 Diabetes on Eliquis for another indication?
Do you avoid empagliflozin in patients with history of amputation?
What patient specific factors outside of health insurance coverage do you use to decide which GLP1 R agonist or dual agonist therapy to start in patients with diabetes?
Is there a role for use of GLP1 R agonist or dual agonist therapy for management of post bariatric hypoglycemia and dumping syndrome?
What is your approach to addressing severe dawn phenomenon in your patients with diabetes?
Which patients would benefit most from teplizumab therapy to delay the onset of T1DM?
